- Home
- CAC vs HUMA Comparison
CAC vs HUMA Comparison
Compare CAC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- HUMA
- Stock Information
- Founded
- CAC 1875
- HUMA 2004
- Country
- CAC United States
- HUMA United States
- Employees
- CAC N/A
- HUMA N/A
- Industry
- CAC Major Banks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- HUMA Health Care
- Exchange
- CAC Nasdaq
- HUMA Nasdaq
- Market Cap
- CAC N/A
- HUMA 584.8M
- IPO Year
- CAC 1997
- HUMA N/A
- Fundamental
- Price
- CAC $43.80
- HUMA $4.61
- Analyst Decision
- CAC Hold
- HUMA Strong Buy
- Analyst Count
- CAC 3
- HUMA 7
- Target Price
- CAC $46.67
- HUMA $13.43
- AVG Volume (30 Days)
- CAC 76.8K
- HUMA 3.9M
- Earning Date
- CAC 01-28-2025
- HUMA 03-21-2025
- Dividend Yield
- CAC 3.84%
- HUMA N/A
- EPS Growth
- CAC N/A
- HUMA N/A
- EPS
- CAC 3.20
- HUMA N/A
- Revenue
- CAC $168,756,000.00
- HUMA N/A
- Revenue This Year
- CAC N/A
- HUMA N/A
- Revenue Next Year
- CAC $30.91
- HUMA $5,584.53
- P/E Ratio
- CAC $13.69
- HUMA N/A
- Revenue Growth
- CAC N/A
- HUMA N/A
- 52 Week Low
- CAC $28.62
- HUMA $2.80
- 52 Week High
- CAC $50.07
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- CAC 51.07
- HUMA 50.08
- Support Level
- CAC $43.09
- HUMA $4.41
- Resistance Level
- CAC $45.29
- HUMA $4.67
- Average True Range (ATR)
- CAC 1.01
- HUMA 0.33
- MACD
- CAC 0.25
- HUMA -0.01
- Stochastic Oscillator
- CAC 69.72
- HUMA 45.04
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.